Recombinant Anti-SARS-CoV Antibody (S230.15) (CAT#: HPAB-0103LY)

This product is antibody recognizes SARS-CoV. The antibody S230.15 immunoassay techniques such as: ELISA, RIA.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
Inhib

Figure 1 Mapping of neutralizing epitopes on the SARS-CoV S glycoprotein recognized by human MAbs through sequence analysis and cross-competition studies.

Figure 1 Mapping of neutralizing epitopes on the SARS-CoV S glycoprotein recognized by human MAbs through sequence analysis and cross-competition studies.

Cross-competition of MAbs binding to the SARS-CoV S glycoprotein. Shown are the percentages of inhibition of the binding of 3 biotinylated MAbs (S109.8, S227.14, and S230.15; concentration, 0.1 μg/ml) to the recombinant SARS-CoV S glycoprotein by a panel of 23 unlabeled competing MAbs (at a saturating concentration [5 μg/ml]) belonging to groups I through VI.

Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008). Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. Journal of virology, 82(7), 3220-3235.

Inhib

Figure 2 Prophylactic treatment of lethal SARS-CoV infections in 10-week-old BALB/c mice with 25 μg of cross-neutralizing MAbs.

Figure 2 Prophylactic treatment of lethal SARS-CoV infections in 10-week-old BALB/c mice with 25 μg of cross-neutralizing MAbs.

Body weights of mice infected with MA15 were measured daily after passive transfer of 25 μg of MAb S109.8 (+), S227.14 (○), S230.15 (×), or D2.2 (□).

Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008). Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. Journal of virology, 82(7), 3220-3235.


Specifications

  • Derivation
  • Mouse
  • Specificity
  • SARS-CoV
  • Species Reactivity
  • SARS-CoV
  • Clone
  • S230.15
  • Applications
  • ELISA, RIA, Inhib

Product Property

  • Purification
  • 95% pure by SDS-PAGE
  • Purity
  • > 95% Purity determined by SDS-PAGE.
  • Format
  • Liquid
  • Buffer
  • PBS, pH 7.4
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Applications

  • Application Notes
  • The SARS-CoV antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Radioimmunoassay, Inhibition.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone S230.15"

See other products for "SARS-CoV"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-0103LY. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare